Chubb, Toast And A Health Care Stock On CNBC’s ‘Final Trades’
Key takeaways
- Chubb, Amgen, and Toast are recommended stocks with strong earnings and guidance, indicating potential for growth and increased stock prices.
- Chubb's second-quarter earnings of $7.26 per share beat the analyst consensus estimate of $6.75 per share
- Amgen's quarterly earnings of $6.29 per share beat the analyst consensus estimate of $5.62 per share
- Toast's quarterly earnings of 26 cents per share beat the analyst consensus estimate of 20 cents per share
What happened
Malcolm Ethridge recommended Chubb Limited, Amgen Inc., and Toast, Inc. as his final trades on CNBC's 'Halftime Report Final Trades'. Chubb beat earnings estimates but missed sales estimates, while Amgen reported better-than-expected financial results and raised guidance. Toast also beat earnings and sales estimates.
Why it matters
These stocks are being recommended by a CNBC contributor, indicating potential interest from investors. Chubb's earnings beat and Amgen's guidance raise suggest strong performance, while Toast's earnings and sales beat indicate growth. This could impact investor sentiment and stock prices.
Short-term and longer-term
Short-term. Over the next day or two, watch the next open for Chubb Toast And, and any same-day update to the year-ahead numbers.
Longer-term. The strong earnings reports from Chubb, Amgen, and Toast suggest a positive market reaction, but the sales misses and declines in stock prices may indicate caution.